Dec 19 (Reuters) - Cyclopharm Ltd (CYC) :
- FY18 REVENUE EXPECTED TO BE IN LINE WITH FY17
- CO RECONFIRMS IT WILL HAVE SUFFICIENT CASH TO COMPLETE USFDA SUBMISSION, FUND RESEARCH AND DEVELOPMENT AND NEAR TERM GROWTH INITIATIVES
News: CYC Cyclopharm Says FY18 Revenue Expected To Be In Line With FY17
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
90.0¢ |
Change
0.020(2.27%) |
Mkt cap ! $97.80M | |||
| Open | High | Low | Value | Volume |
| 91.0¢ | 91.0¢ | 89.0¢ | $7.998K | 8.922K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1222 | 88.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 9273 | 2 |
View Market Depth
| Last trade - 10.19am 24/06/2025 (20 minute delay) ? |
| CYC (ASX) Chart |